Results

Total Results: 525 records

Showing results for "diabetes guidelines".
Users also searched for: diabetes screening

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
    May 16, 2013 - factors in predicting the risk of AF recurrence (e.g., age, gender, body mass index, hypertension, diabetes … recurrence) Age (p=0.14), body mass index (p=0.93), duration of AF (p=0.32), hypertension (p=0.67) , or diabetes … severe LA scarring as a predictor of PH) OR=9.49, 95% CI: 2.0, 44.2 [MVA] (baseline presence of diabetes … antrum isolatation; MS=metabolic syndrome; CHADS=congestive heart failure, hypertension, age>75 years, diabetes
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_executive.pdf
    May 01, 2013 - nutritional status, incontinence, and specific medical comorbidities that affect circulation such as diabetes … age, race or skin tone, physical impairment, body weight, or specific medical comorbidities (e.g., diabetes … physical impairment, body weight, or specific medical comorbidities (e.g., urinary incontinence, diabetes … WOCN update on evidence-based guidelines for pressure ulcers.
  3. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
    April 15, 2019 - registries as valuable mechanisms for structuring quality improvement programs, informing clinical guidelines … repository of common data elements (CDEs), metadata, and data standards used in cancer research.54 Diabetes … Data Strategy (Diabe-DS) Data harmonization Created common data elements for Type 1 diabetes using a … , which are considered surrogate outcomes of cardiovascular health or the health of patients with diabetes
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
    September 20, 2013 - metabolic and other maternal conditions (such as diabetes … Searching CINAHL did not add value to clinical questions posed in NICE guidelines.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment-future_research.pdf
    September 01, 2012 - instance, some practitioners were also members of professional societies and organizations who make guidelines … Kuwait: Dasman Diabetes Institute; 2012. http://clinicaltrials.gov/ct2/show/NCT01509 443.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
    January 01, 2014 - offer services for at least four of seven core chronic diseases: hypertension, chronic heart failure, diabetes … Contextual Factors CMS guidelines require that MTM be delivered by a pharmacist or other qualified
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
    March 01, 2011 - This report may be used, in whole or in part, as the basis for development of clinical practice guidelines … For example, in a study evaluating glycemic control in patients with type 2 diabetes, 4 patients
  8. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/strategies-integrating-behavioral-health-protocol.pdf
    August 04, 2022 - cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - FM criteria: pain for ≥6 months and confirmation of FM by tender point testing, using guidelines established … 55% Arthritis in other joints: 24% vs. 21% vs. 15% Cardiovascular disease: 13% vs. 6% vs. 11% Type 2 diabetes … than 12 weeks and with no underlying inflammatory or neoplastic disease Exclusion: Patients with diabetes
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - FM criteria: pain for ≥6 months and confirmation of FM by tender point testing, using guidelines established … 55% Arthritis in other joints: 24% vs. 21% vs. 15% Cardiovascular disease: 13% vs. 6% vs. 11% Type 2 diabetes … than 12 weeks and with no underlying inflammatory or neoplastic disease Exclusion: Patients with diabetes
  11. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - operation nationwide, and a multigroup task force has developed the Geriatric Emergency Department Guidelines … , especially in those requiring ongoing daily medication use for conditions such as tuberculosis, diabetes … Manufacturers provide guidelines for imaging done by the clinician to ensure specifications (e.g.,
  12. effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
    January 01, 2014 - Krystexxa) for treatment of chronic gout Clinical Pathway at Point of This Intervention Clinical guidelines … for gout indications in mid-2011. 24 Clinical Pathway at Point of This Intervention Clinical guidelines … injections can be met with resistance as evidenced by poor adherence to treatment in patients with diabetes
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
    April 01, 2012 - trials.10 Two reviewers assessed the included studies for sources of systematic bias according to the guidelines … The World Glaucoma Association publication Guidelines on Design and Reporting of Glaucoma Surgical … Guidelines on Design and Reporting of Glaucoma Surgical Trials.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_disposition-comments.pdf
    August 21, 2013 - explicitly re: treatment positively impacting recidivism for reasons similar to effective treatment for diabetes … The results do not report any new information or useful guidelines for practice.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
    November 30, 2014 - age, female sex, chronic diarrhea, nerve damage (such as from injury, multiple sclerosis, or chronic diabetes … Our findings will provide evidence support for FI treatment guidelines by physicians’ groups and for
  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - Layout 1 Background Gastroesophageal reflux disease (GERD) is one of the most common health conditions affecting Americans. A study of an employed population in the United States estimated that more than 11,000 of 267,000 employees (4 percent) suffered from GERD, contributing an average incremental cost to the emplo…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
    December 15, 2015 - inclusion and exclusion criteria are acceptable but not well justified beyond the attribution to the AHRQ guidelines … work about effects of PHR- delivered interventions on medication reconciliation (Schnipper 2009), diabetes … people taking medicines, clinicians and guidelines? … We now note this was patient adherence to taking medications prescribed based on evidence-based guidelines
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
    January 01, 2014 - , study period, followup), study participants (e.g., age, sex, duration of ulcer, smoking status, diabetes … We collected data on subgroups of interest (e.g., age, presence of comorbid conditions [diabetes, obesity … Known Our findings are in concert with previous published large reviews and evidence-based practice guidelines
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - This report may be used, in whole or in part, as the basis for development of clinical practice guidelines … Search strategies are described elsewhere.14 Following FDA and other professional guidelines, We … the time of recruitment, patients with severe hepatic or renal disease, glaucoma, or uncontrolled diabetes … RCT Taiwan N: 74 Pregnancy, neurologic disorders, diabetes mellitus, demand cardiac pacemaker
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
    February 01, 2012 - placebo-controlled trials that adhere to the high standards required for synthesis and use in treatment guidelines

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: